COMPASS Pathways granted fifth US patent for crystalline psilocybin Post published:November 23, 2021 Post category:Press Release
Cybin Awards Grant for Psychedelic Treatment Clinic at Lenox Hill Hospital to Benefit Underserved Communities Post published:November 23, 2021 Post category:Press Release
Numinus to Host Q4 and 2021 Annual Results Conference Call on December 9, 2021 Post published:November 22, 2021 Post category:Press Release
HAVN Life Successfully Exports Psilocybin from its Jamaica Facility into Canada Post published:November 22, 2021 Post category:Press Release
PsyBio Therapeutics Furthers Intellectual Property Portfolio with Six New Manufacturing Patent Applications Post published:November 19, 2021 Post category:Press Release
Numinus to Begin Trading on the OTC Under Symbol NUMIF Post published:November 19, 2021 Post category:Press Release
Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human Stroke Study Post published:November 19, 2021 Post category:Press Release
Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments Post published:November 19, 2021 Post category:Press Release
Tryp Therapeutics Provides Update on Clinical Hold for Phase 2a Study for Eating Disorders Post published:November 18, 2021 Post category:Press Release
Filament Health Announces Co-Development and Exclusive Licensing Agreement with Entheotech Bioscience Post published:November 18, 2021 Post category:Press Release